83257-001-11 |
83257-001 |
HUMAN PRESCRIPTION DRUG |
OGIVRI |
trastuzumab-dkst |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20231001 |
N/A |
BLA |
BLA761074 |
Biocon Biologics Inc. |
TRASTUZUMAB |
150 mg/7.4mL |
1 VIAL in 1 CARTON (83257-001-11) / 15 mL in 1 VIAL |
67457-991-15 |
67457-991 |
HUMAN PRESCRIPTION DRUG |
OGIVRI |
trastuzumab |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20191129 |
20270228 |
BLA |
BLA761074 |
Mylan Institutional LLC |
TRASTUZUMAB |
150 mg/7.4mL |
1 VIAL in 1 CARTON (67457-991-15) / 15 mL in 1 VIAL |
67457-847-44 |
67457-847 |
HUMAN PRESCRIPTION DRUG |
OGIVRI |
trastuzumab |
KIT |
|
20191129 |
20270430 |
BLA |
BLA761074 |
Mylan Institutional LLC |
|
|
1 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20) |
83257-004-12 |
83257-004 |
HUMAN PRESCRIPTION DRUG |
OGIVRI |
trastuzumab-dkst |
KIT |
|
20231001 |
N/A |
BLA |
BLA761074 |
Biocon Biologics Inc. |
|
|
1 KIT in 1 CARTON (83257-004-12) * 20 mL in 1 VIAL, MULTI-DOSE (83257-003-11) * 20 mL in 1 VIAL (83257-002-11) |